Effectiveness in Limiting the Need to Elevate the Maxillary Sinus (SO-GHI)
Alveolar Bone Loss
About this trial
This is an interventional treatment trial for Alveolar Bone Loss focused on measuring alveolar ridge preservation
Eligibility Criteria
Inclusion Criteria:
- indication for extraction of the first or second upper molar, based on a thorough diagnosis and treatment plan;
- "three-rooted" anatomy of the first or second upper molar to be extracted so that it can have an inter-radicular septum that allows a precise measurement of the height of the bone ridge from the septum itself and from the walls of the 3 alveoli to the floor of the maxillary sinus;
- Extraction of intercalate molar or last arch element;
Exclusion Criteria:
- Anatomy of the molar with unique root or fused roots
- contextual extraction of the molar and one or more contiguous elements
- apical lesions with a diameter of> 3 mm or cystic lesions with respect to the element to be extracted
- root fracture which has produced resorption or bone fenestration
1) acute myocardial infarction in the last six months; 2) uncontrolled clotting disorders; 3) uncontrolled diabetes (HBA1c> 7.5%); 4) radiotherapy in the head / neck district for the last 24 months; 5) immunocompromise (eg HIV infection or chemotherapy over the last 3 years); 6) treatment in progress or with bisphosphonates via e.v .; 7) autoimmune diseases in chronic therapy with methotrexate or other immunosuppressive drugs; 8) allergy to bovine collagen; 9) psychological or psychiatric problems; 10) abuse of alcohol or drug use; 11) uncontrolled periodontal disease;
Sites / Locations
- Piezosurgery Academy
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
synthetic
collagen
alveolar ridge preservation with synthetic bone
alveolar ridge preservation with bovine collagen